Around 30% of adults globally suffer from steatotic liver disease, commonly known as fatty liver, a potentially life-threatening condition linked to unhealthy diets and lifestyles.

Few people exhibit visible symptoms in the disease’s initial stages. Early screening can make a big difference, enabling timely treatment and lifestyle changes.

Eieling Technology has developed a palm-sized diagnostic tool, Liverscan, that costs about half as much as conventional methods and is quicker and easier to use, lowering the barriers to mass testing.

Increasing number of hospitals and clinics – mainly in the Chinese Mainland, Hong Kong and Macao so far – are using this groundbreaking device.

The medtech firm has subsequently introduced its handheld scanner in ASEAN and Egypt, reflecting demand for an affordable, non-specialist option in low- and middle-income countries.  

Liverscan made its overseas debut in April 2025 in Vietnam, where the scanner has been installed in hospitals and clinics in Ho Chi Minh City and Da Nang.

Eieling secured its foothold in its first overseas market with the support of the Ho Chi Minh City office of the Hong Kong Trade Development Council (HKTDC), which arranged meetings with healthcare product distributors and provided detailed market information.

Paving the way for widespread adoption around the world, Liverscan has also been approved for use in China and the US.

Executives expect to secure the green light from European Union regulators soon and are engaging with authorities in India and Pakistan.

Distribution discussions are underway in 30 markets.

“We anticipate a surge in Liverscan’s overseas revenue in 2026,” Eieling Technology’s Global Product Lead, Ginger Jiang, says.

As personal health monitoring becomes more common, the liver health specialist is expanding into the consumer market.

In May 2025, it unveiled FattaLab, a lightweight medical-grade device that can be used at home as well as in clinics and community centres.

The new product is already on sale in Hong Kong and Macao, with approvals for major overseas markets anticipated this year.

“We hope that FattaLab will one day appear on our bedside tables, just like thermometers and blood pressure monitors, becoming a gateway to home health management,” Ms Jiang remarks.

Eieling Technology presented FattaLab and Liverscan at the Asia Summit on Global Health, a health innovation and investment platform co-organised by the Hong Kong SAR Government and the HKTDC, as well as the concurrent Hong Kong International Medical and Healthcare Fair.

Both events took place at the same time as FattaLab’s official launch.

Participating in these events has enabled the company to ramp up its business expansion and engineering breakthroughs.

These and other HKTDC-led events, such as next-gen tech fair InnoEX, have helped it link up with multiple partners from around the world, including buyers, distributors, investors and research institutions, Ms Jiang explains.

“The HKTDC helps Eieling Technology overcome geographical limitations, deepen technological cooperation and capture growth opportunities.”

In January this year, the innovator presented FattaLab at CES in Las Vegas, as part of the Hong Kong Tech Pavilion organised by Hong Kong Science and Technology Parks Corporation and the HKTDC.

FattaLab won a prestigious Innovation Award at the tech fair.

The HKTDC has also provided wide-ranging support for Eieling Technology’s ongoing growth trajectory through its network of overseas offices as well as business development support programmes, such as GoGBA.

We helped them foster partnerships and identify new possibilities in high-growth medtech markets, including the Guangdong-Hong Kong-Macao Greater Bay Area, ASEAN, the Middle East and US.

During GITEX Global in Dubai in October last year, for example, the HKTDC’s local office facilitated key introductions with stakeholders in the healthcare ecosystem, including government authorities, medical equipment traders and hospitals, opening doors to future expansion in the United Arab Emirates.

The HKTDC-organised business matching, media interviews and networking events provide a solid foundation for entry into new markets, Ms Jiang notes.

The company spun out of The Hong Kong Polytechnic University in 2018, led by Prof Zheng Yongping, a biomedical engineer and Director of the university’s Research Institute for Smart Ageing.